[XUNLEI ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2020 Shenzhen, China, May 14, 2020 (GLOBE NEWSWIRE) – Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced its un]
[CHINA AUTOMOTIVE SYSTEMS, INC. FORM 10-K INDEX Page PART I Item 1. Business. 4 Item 1A. Risk Factors. 4] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-126959) of China Automotive Systems]
[ATA Creativity Global Announces Receipt of NASDAQ Notice of Failure to Satisfy Bid Price Continued Listing Requirement ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG) Notice Nasdaq ADSs Beijing, China, May 14, 2020 (NY) / May 15, 2020 (China) — The Notice explained that given the extrao]
[CHINA AUTOMOTIVE SYSTEMS, INC. FORM 10-K INDEX Page PART I Item 1. Business. 4 Item 1A. Risk Factors. 4] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-126959) of China Automotive Systems]
[ATA Creativity Global Announces Receipt of NASDAQ Notice of Failure to Satisfy Bid Price Continued Listing Requirement ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG) Notice Nasdaq ADSs Beijing, China, May 14, 2020 (NY) / May 15, 2020 (China) — The Notice explained that given the extrao]
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
[EXPLANATORY NOTE Upon effectiveness of the Reverse Stock Split, every 10 outstanding shares of our common stock were, without any further action by us, or any holder thereof, combined into and automatically became 1 share of our common stock, and 100,000,000 authorized shares of our common stock bec]
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
[EXPLANATORY NOTE Upon effectiveness of the Reverse Stock Split, every 10 outstanding shares of our common stock were, without any further action by us, or any holder thereof, combined into and automatically became 1 share of our common stock, and 100,000,000 authorized shares of our common stock bec]
